SEC-sourced researchBeta
CAI
Caris Life Sciences, Inc.
Company comparison ↗
Data passport
- CIK
- 0002019410
- Exchange
- Nasdaq
- Business activity
- Services-Medical Laboratories · SIC 8071
- Financial inputs
- 6/6
- Filing date
- Nov 5, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2023 | 306,128,000.0000 | Mar 3, 2026 |
| December 2024 | 412,260,000.0000 | Mar 3, 2026 |
| December 2025 | 812,033,000.0000 | Mar 3, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 812,033,000.0000 | -68,088,000.0000 | 83,155,000.0000 | 1,125,663,000.0000 | 548,356,000.0000 | Mar 3, 2026 |
| December 2024 | 412,260,000.0000 | -281,890,000.0000 | -245,199,000.0000 | 343,734,000.0000 | 620,921,000.0000 | Mar 3, 2026 |
| December 2023 | 306,128,000.0000 | -341,415,000.0000 | -276,100,000.0000 | — | — | Mar 3, 2026 |
Explainable fundamental score
Five equally weighted components based on SEC financial inputs. No price inputs or personal investment preferences.
71/100
Profitability33
Growth100
Balance sheet51
Cash generation70
Data coverage100
Component weight: 20% · Minimum data coverage: 50% · Missing component value: 50/100
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $812.03M | Jan 1, 2025 – Dec 31, 2025 | Mar 3, 2026 | 10-K |
| Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax | $412.26M | Jan 1, 2024 – Dec 31, 2024 | Mar 3, 2026 | 10-K |
| Net incomeNetIncomeLoss | -$68.09M | Jan 1, 2025 – Dec 31, 2025 | Mar 3, 2026 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | $83.16M | Jan 1, 2025 – Dec 31, 2025 | Mar 3, 2026 | 10-K |
| Total assetsAssets | $1.13B | Dec 31, 2025 | Mar 3, 2026 | 10-K |
| Total liabilitiesLiabilities | $548.36M | Dec 31, 2025 | Mar 3, 2026 | 10-K |